This invention relates generally to the use of annexin II for the purpose of stabilizing a hyaluronidase enzyme for administration to the eyes of humans or other mammals.

 
Web www.patentalert.com

< Methods of treating schizophrenia

< Methods of nucleic acid amplification and sequencing

> Chemically-defined non-polymeric valency platform molecules and conjugates thereof

> Compositions and methods for WT1 specific immunotherapy
~ 00293